Medigen Vaccine Biologics Corporation (6547.TWO)
TWD 43.55
(-9.93%)
TWD 43.55
(-9.93%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 230.22 Million TWD | 204.02% |
| 2022 | -212.6 Million TWD | -109.22% |
| 2021 | 2.3 Billion TWD | 30086.39% |
| 2020 | 7.63 Million TWD | 581.79% |
| 2019 | 1.12 Million TWD | 101.11% |
| 2018 | -101.02 Million TWD | -21.99% |
| 2017 | -82.81 Million TWD | -331.72% |
| 2016 | -19.18 Million TWD | -49.81% |
| 2015 | -12.8 Million TWD | 0.0% |
| 2014 | - TWD | 0.0% |
| 2013 | - TWD | 0.0% |
| 2012 | - TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 126.35 Million TWD | 418.01% |
| 2024 Q1 | 24.39 Million TWD | -79.13% |
| 2024 Q3 | 139.26 Million TWD | 10.22% |
| 2023 Q4 | 116.85 Million TWD | 4.96% |
| 2023 Q1 | -32.51 Million TWD | 92.26% |
| 2023 Q3 | 111.33 Million TWD | 439.75% |
| 2023 Q2 | -32.76 Million TWD | -0.78% |
| 2023 FY | 221.14 Million TWD | 204.02% |
| 2022 Q4 | -419.91 Million TWD | -20553.63% |
| 2022 Q2 | -4.8 Million TWD | -102.29% |
| 2022 Q1 | 210.06 Million TWD | -85.31% |
| 2022 FY | -212.6 Million TWD | -109.22% |
| 2022 Q3 | 2.05 Million TWD | 142.7% |
| 2021 Q2 | 180 Thousand TWD | -73.57% |
| 2021 Q4 | 1.43 Billion TWD | 63.67% |
| 2021 Q1 | 681 Thousand TWD | -85.34% |
| 2021 FY | 2.3 Billion TWD | 30086.39% |
| 2021 Q3 | 873.88 Million TWD | 485393.33% |
| 2020 Q3 | 1.62 Million TWD | 84.69% |
| 2020 FY | 7.63 Million TWD | 581.79% |
| 2020 Q2 | 882 Thousand TWD | 83.75% |
| 2020 Q1 | 480 Thousand TWD | 0.0% |
| 2020 Q4 | 4.64 Million TWD | 185.14% |
| 2019 Q3 | - TWD | -100.0% |
| 2019 FY | 1.12 Million TWD | 101.11% |
| 2019 Q4 | 480 Thousand TWD | 0.0% |
| 2019 Q2 | 640 Thousand TWD | 0.0% |
| 2019 Q1 | - TWD | 0.0% |
| 2018 Q4 | - TWD | 0.0% |
| 2018 FY | -101.02 Million TWD | -21.99% |
| 2018 Q2 | - TWD | 0.0% |
| 2018 Q1 | - TWD | 0.0% |
| 2018 Q3 | - TWD | 0.0% |
| 2017 FY | -82.81 Million TWD | -331.72% |
| 2017 Q4 | - TWD | 0.0% |
| 2017 Q2 | - TWD | 0.0% |
| 2017 Q3 | - TWD | 0.0% |
| 2017 Q1 | - TWD | 0.0% |
| 2016 Q4 | - TWD | 0.0% |
| 2016 Q3 | - TWD | 0.0% |
| 2016 Q1 | - TWD | 0.0% |
| 2016 Q2 | - TWD | 0.0% |
| 2016 FY | -19.18 Million TWD | -49.81% |
| 2015 Q3 | - TWD | 0.0% |
| 2015 Q1 | - TWD | 0.0% |
| 2015 Q2 | - TWD | 0.0% |
| 2015 FY | -12.8 Million TWD | 0.0% |
| 2015 Q4 | - TWD | 0.0% |
| 2014 FY | - TWD | 0.0% |
| 2014 Q4 | - TWD | 0.0% |
| 2014 Q3 | - TWD | 0.0% |
| 2014 Q2 | - TWD | 0.0% |
| 2014 Q1 | - TWD | 0.0% |
| 2013 FY | - TWD | 0.0% |
| 2012 FY | - TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -69876.292% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 42.808% |
| Level Biotechnology Inc. | 219.54 Million TWD | -4.863% |
| Sagittarius Life Science Corp | 71.47 Million TWD | -222.092% |
| NeoCore Technology Co., Ltd. | -9.08 Million TWD | 2634.089% |
| TaiMed Biologics Inc. | 225.23 Million TWD | -2.215% |
| GlycoNex Incorporation | 995 Thousand TWD | -23037.889% |
| VBI | 16.42 Million TWD | -1301.827% |
| GeneReach Biotechnology Corp. | 27.58 Million TWD | -734.622% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | -16.007% |
| SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | -44088.484% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | -91.996% |
| Visgeneer Inc. | 67.48 Million TWD | -241.161% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 161.361% |
| Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 83.613% |
| G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | -59.227% |
| Neith Corporation | 18.01 Million TWD | -1177.662% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -912.321% |
| Enimmune corporation | -23.37 Million TWD | 1084.991% |
| TaiRx, Inc. | 2.43 Million TWD | -9339.196% |
| CHO Pharma, Inc. | -28.27 Million TWD | 914.109% |
| EirGenix Inc. | 236.74 Million TWD | 2.754% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -120.623% |
| Sunny Pharmtech Inc. | 285.52 Million TWD | 19.369% |
| Lin BioScience, Inc. | -17.92 Million TWD | 1384.219% |
| BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | -156.893% |
| Feng Chi Biotech Corp. | 80.72 Million TWD | -185.207% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -21157.802% |
| Lukas Biomedical Inc. | 133.89 Million TWD | -71.949% |
| RBC Bioscience Corporation | 72.89 Million TWD | -215.827% |
| BiOptic Inc. | 152.74 Million TWD | -50.723% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -255702.222% |
| Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | -3353.157% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -8703.901% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 64.247% |
| Advagene Biopharma Co., Ltd. | -12 Million TWD | 2018.197% |
| NaviFUS Corp. | 11.82 Million TWD | -1846.58% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | -137.897% |
| Sinew Pharma Inc. | -28.98 Million TWD | 894.28% |
| Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -73453.355% |
| Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 41.338% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -455.006% |
| AP Biosciences Inc | 32.25 Million TWD | -613.8% |
| Medigen Biotechnology Corp. | 617.32 Million TWD | 62.707% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -4265.226% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 26.797% |
| Intech Biopharm Corporation | -163.99 Million TWD | 240.384% |
| Oneness Biotech Co., Ltd. | 32.56 Million TWD | -607.027% |
| Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 5814.123% |
| TWi Biotechnology, Inc. | -9.73 Million TWD | 2463.918% |
| Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 52.507% |
| TCI GENE Inc. | 174.61 Million TWD | -31.844% |
| MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 1486.796% |
| Senhwa Biosciences, Inc. | -10.17 Million TWD | 2363.069% |
| Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | -201.499% |
| NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | -199.133% |
| PharmaEngine, Inc. | 718.97 Million TWD | 67.979% |
| Savior Lifetec Corporation | 220.94 Million TWD | -4.197% |
| TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | -106.133% |
| OBI Pharma, Inc. | -73.49 Million TWD | 413.24% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | -65.782% |
| Acepodia, Inc. | 16.59 Million TWD | -1287.465% |
| Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | -738.116% |